Hypertension during intravenous immune globulin infusion for Kawasaki's disease: an underreported phenomenon?

Clin Pediatr (Phila). 2015 May;54(5):491-3. doi: 10.1177/0009922814536776. Epub 2014 Jun 4.

Authors

Margaret Kissel¹, Colin K L Phoon², Philip J Kahn³

Affiliations

¹ Yale Medical Center, New Haven, CT, USA.
² New York University Langone Medical Center, New York, NY, USA.
³ New York University Langone Medical Center, New York, NY, USA philip.kahn@nyumc.org.

PMID: 24899632
DOI: 10.1177/0009922814536776

No abstract available

Publication types

Case Reports

MeSH terms

Antihypertensive Agents / therapeutic use
Child, Preschool
Female
Humans
Hypertension / complications*
Hypertension / drug therapy
Immunoglobulins, Intravenous / therapeutic use*
Labetalol / therapeutic use
Mucocutaneous Lymph Node Syndrome / complications*
Mucocutaneous Lymph Node Syndrome / drug therapy*

Substances

Antihypertensive Agents
Immunoglobulins, Intravenous
Labetalol